Financial Gravity Asset Management, Inc. Regenxbio Inc. Transaction History

Financial Gravity Asset Management, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 08, 2023	BUY	$17.23 - $21.71 $344 - $434	20 New	20 $248,000
Q4 2022 Feb 15, 2023	SELL	$20.4 - $24.73 $7,486 - $9,075	-367 Reduced 94.1%	23 $249,000
Q3 2022 Nov 03, 2022	BUY	$22.29 - $35.04 $8,693 - $13,665	390 New	390 $1.96 Million
Q2 2019 Jul 26, 2019	SELL	$42.0 - $59.29 $39,690 - $56,029	-945 Closed	0 $0
Q1 2019 Apr 19, 2019	BUY	$40.82 - $62.45 $11,062 - $16,923	271 Added 40.21%	945 $55,000

Q3 2018 Oct 31, 2018	BUY	$65.0 - $82.15 $43,810 - $55,369	674 New	674 $41,000

192

42.6M

80.6K

55.2K

Ticker RGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,230,000
Market Cap $590M
Description
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...

Get notified when there are updates to the investment portfolio of Financial Gravity Asset Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Financial Gravity Asset Management, Inc. with notifications on news.